Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study. (Q36565634)

From Wikidata
Revision as of 00:09, 15 August 2017 by Research Bot (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article
Language Label Description Also known as
English
Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study.
scientific article

    Statements

    title
    Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study. (English)
    1 reference
    stated in
    Europe PubMed Central
    PMC publication ID
    3556255
    retrieved
    15 August 2017

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q36565634&oldid=538055403"